Princeton Capital Management Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Princeton Capital Management Inc's PFE Position: Q3 2017 in Review
Princeton Capital Management Inc increased its Pfizer (PFE) stake by 33% in Q3 2017, buying an estimated $1.16M and bringing the position to 146,312 shares worth $4.96M. The position accounts for 2.51% of the portfolio, ranked #15.
Princeton Capital Management Inc first reported a position in PFE in Q1 2016 and has held it in 7 quarters since. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.
- Princeton Capital Management Inc held 146,312 shares of Pfizer worth $4.96M as of Q3 2017.
- Princeton Capital Management Inc bought 36,018 Pfizer shares in Q3 2017, an estimated $1.16M.
- Pfizer made up 2.51% of Princeton Capital Management Inc's portfolio in Q3 2017, its #15 holding.
- Princeton Capital Management Inc first reported a position in Pfizer in Q1 2016 and has held it in 7 quarters since.
- 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.
Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.